UTStarcom CDM1450 - Manual (Page 68)

134 135
The National Institutes of Health participates in some interagency working group
activities, as well.
FDA shares regulatory responsibilities for wireless phones with the Federal
Communications Commission (FCC). All phones that are sold in the United States
must comply with FCC safety guidelines that limit RF exposure. FCC relies on FDA
and other health agencies for safety questions about wireless phones.
FCC also regulates the base stations that the wireless phone networks rely upon.
While these base stations operate at higher power than do the wireless phones
themselves, the RF exposures that people get from these base stations are
typically thousands of times lower than those they can get from wireless phones.
Base stations are thus not the primary subject of the safety questions discussed
in this document.
4. What are the results of the research done already?
The research done thus far has produced conflicting results, and many studies
have suffered from flaws in their research methods. Animal experiments
investigating the effects of radiofrequency energy (RF) exposures characteristic of
wireless phones have yielded conflicting results that often cannot be repeated in
other laboratories. A few animal studies, however, have suggested that low levels
of RF could accelerate the development of cancer in laboratory animals. However,
many of the studies that showed increased tumor development used animals that
had been genetically engineered or treated with cancer-causing chemicals so as to
be pre-disposed to develop cancer in the absence of RF exposure.
Other studies exposed the animals to RF for up to 22 hours per day. These
conditions are not similar to the conditions under which people use wireless
phones, so we don’t know with certainty what the results of such studies mean
for human health.
SAFETY
difficulty in reproducing those studies, or in determining the reasons for
inconsistent results.
3 . What is FDA's role concerning the safety of wireless phones?
Under the law, FDA does not review the safety of radiation-emitting consumer
products such as wireless phones before they can be sold, as it does with new
drugs or medical devices. However, the agency has authority to take action if
wireless phones are shown to emit radiofrequency energy (RF) at a level that is
hazardous to the user. In such a case, FDA could require the manufacturers of
wireless phones to notify users of the health hazard and to repair, replace or recall
the phones so that the hazard no longer exists.
Although the existing scientific data do not justify FDA regulatory actions, FDA
has urged the wireless phone industry to take a number of steps, including the
following:
• Support needed research into possible biological effects of RF of the type
emitted by wireless phones;
• Design wireless phones in a way that minimizes any RF exposure to the user
that is not necessary for device function; and
• Cooperate in providing users of wireless phones with the best possible
information on possible effects of wireless phone use on human health
FDA belongs to an interagency working group of the federal agencies that have
responsibility for different aspects of RF safety to ensure coordinated efforts at the
federal level. The following agencies belong to this working group:
• National Institute for Occupational Safety and Health
• Environmental Protection Agency
• Federal Communications Commission
• Occupational Safety and Health Administration
• National Telecommunications and Information Administration
SAFETY
071012_1450M-EN_REV01.indd 134-135 071012_1450M-EN_REV01.indd 134-135 2007.12.17 10:21:31 AM 2007.12.17 10:21:31 AM